Trial Profile
Safety and pharmacokinetic study of telaprevir based therapy in patients with hepatitis c virus recurrence post-liver transplant
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Dec 2015
Price :
$35
*
At a glance
- Drugs Telaprevir (Primary) ; Peginterferon alfa-2a; Ribavirin; Tacrolimus
- Indications Hepatitis C
- Focus Adverse reactions; Pharmacokinetics
- 16 Dec 2015 New trial record